-Adrenoreceptors Reactivate Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication via PKA-Dependent Control of Viral RTA

Department of Microbiology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-1678,USA.
Journal of Virology (Impact Factor: 4.44). 12/2005; 79(21):13538-47. DOI: 10.1128/JVI.79.21.13538-13547.2005
Source: PubMed


Reactivation of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic replication is mediated by the viral RTA transcription
factor, but little is known about the physiological processes controlling its expression or activity. Links between autonomic
nervous system activity and AIDS-associated Kaposi's sarcoma led us to examine the potential influence of catecholamine neurotransmitters.
Physiological concentrations of epinephrine and norepinephrine efficiently reactivated lytic replication of KSHV in latently
infected primary effusion lymphoma cells via β-adrenergic activation of the cellular cyclic AMP/protein kinase A (PKA) signaling
pathway. Effects were blocked by PKA antagonists and mimicked by pharmacological and physiological PKA activators (prostaglandin
E2 and histamine) or overexpression of the PKA catalytic subunit. PKA up-regulated RTA gene expression, enhanced activity of the RTA promoter, and posttranslationally enhanced RTA's trans-activating capacity for its own promoter and heterologous lytic promoters (e.g., the viral PAN gene). Mutation of predicted phosphorylation targets at RTA serines 525 and 526 inhibited PKA-mediated enhancement of RTA
trans-activating capacity. Given the high catecholamine levels at sites of KSHV latency such as the vasculature and lymphoid organs,
these data suggest that β-adrenergic control of RTA might constitute a significant physiological regulator of KSHV lytic replication.
These findings also suggest novel therapeutic strategies for controlling the activity of this oncogenic gammaherpesvirus in

11 Reads
  • Source
    • "Pharmacologic and molecular dissection of these models has identified a diverse array of gene modules that appear to play a role in mediating such effects, including glucocorticoid-induced activation of the SGK1 gene and associated inhibition of the key tumor suppressor p53 (Feng et al., 2012), and b-adrenergic induction of genes involved in macrophage recruitment and inflammation (Sloan et al., 2010), induction of pro-inflammatory cytokine genes such as IL6 and IL8 by tumor cells (Cole et al., 2010; Nilsson et al., 2007; Shahzad et al., 2010) and immune cells (Cole et al., 2010), VEGF-mediated increases in angiogenesis (Chakroborty et al., 2009; Thaker et al., 2006; Yang et al., 2006), matrix metalloproteinase-related increases in tissue invasion (Landen et al., 2007; Sood et al., 2006; Yang et al., 2006), tumor cell mobilization and motility (Drell et al., 2003; Lang et al., 2004; Palm et al., 2006), FAKmediated resistance to anoikis/apoptosis (Sood et al., 2010), BADmediated resistance to chemotherapy-induced apoptosis (Sastry et al., 2007), and RANKL-mediated modulation of osteoclast function and bone metastasis (Campbell et al., 2012). Other studies have also shown that glucocorticoids can up-regulate a diverse array of genes involved in cell survival and resistance to chemotherapy (Kamradt et al., 2000a; Mikosz et al., 2001; Moran et al., 2000; Pang et al., 2006; Petrella et al., 2006; Wu et al., 2004, 2005), and activate oncogenic viruses such as Epstein–Barr Virus (EBV) (Cacioppo et al., 2002; Glaser et al., 1995; Yang et al., 2010) and Human Papilloma Viruses (Kamradt et al., 2000b; Mittal et al., 1993; Pater et al., 1988), and that b-adrenergic signaling can inhibit p53-med- iated DNA repair (Hara et al., 2011), inhibit expression of Type I interferons (Collado-Hidalgo et al., 2006; Sloan et al., 2010) and interleukin 12 (Goldfarb et al., 2011), upregulate the Her2 signaling pathway implicated in breast cancer (Gu et al., 2009; Shi et al., 2011), stimulate arachadonic acid signaling (Cakir et al., 2002), activate gene expression by tumor-promoting viruses such as HHV-8 (Antoni et al., 2006; Chang et al., 2005), and upregulate the SNAI2 transcription factor regulating epithelial–mesenchymal transition (S. Cole, S. Lutgendorf, and A. Sood, personal communication ). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Genomics-based analyses have provided deep insight into the basic biology of cancer and are now clarifying the molecular pathways by which psychological and social factors can regulate tumor cell gene expression and genome evolution. This review summarizes basic and clinical research on neural and endocrine regulation of the cancer genome and its interactions with the surrounding tumor microenvironment, including the specific types of genes subject to neural and endocrine regulation, the signal transduction pathways that mediate such effects, and therapeutic approaches that might be deployed to mitigate their impact. Beta-adrenergic signaling from the sympathetic nervous system has been found to up-regulated a diverse array of genes that contribute to tumor progression and metastasis, whereas glucocorticoid-regulated genes can inhibit DNA repair and promote cancer cell survival and resistance to chemotherapy. Relationships between socio-environmental risk factors, neural and endocrine signaling to the tumor microenvironment, and transcriptional responses by cancer cells and surrounding stromal cells are providing new mechanistic insights into the social epidemiology of cancer, new therapeutic approaches for protecting the health of cancer patients, and new molecular biomarkers for assessing the impact of behavioral and pharmacologic interventions.
    Brain Behavior and Immunity 11/2012; 30. DOI:10.1016/j.bbi.2012.11.008 · 5.89 Impact Factor
  • Source
    • "Central to this process is the fact that all major human tumor-associated viruses have been found to be responsive to beta-adrenergic receptor (ADRB) or glucocorticoid-dependent signaling cascades. For example, human herpesvirus 8, which induces Kaposi's sarcoma, possesses a cyclic adenosine monophosphate (cAMP) response element in the promoter of an important viral transcription factor (Chang et al., 2005). Additionally, ADRB stimulation of the viral host cell has been shown to increase cAMP response element binding (CREB)mediated expression of viral oncogenes and growth factors that Fig. 1. "
    [Show abstract] [Hide abstract]
    ABSTRACT: During the past decade, new studies have continued to shed light on the role of neuroendocrine regulation of downstream physiological and biological pathways relevant to cancer growth and progression. More specifically, our knowledge of the effects of the sympathetic nervous system (SNS) on cancer biology has been greatly expanded by new data demonstrating how the cellular immune response, inflammatory processes, tumor-associated angiogenesis, and tumor cell invasion and survival converge to promote tumor growth. This review will summarize these studies, while synthesizing clinical, cellular and molecular research that has continued to unearth the biological events mediating the interplay between SNS-related processes and cancer progression.
    Brain Behavior and Immunity 06/2012; 30. DOI:10.1016/j.bbi.2012.06.005 · 5.89 Impact Factor
  • Source
    • "Increased intracellular Ca 2+ activated KSHV in a calcineurin/NFAT pathway in PEL and microvascular endothelial cells (MVEC) (Zoeteweij et al., 2001). The cAMP/PKA pathway activated by epinephrine/norepinephrine through β-adrenoreceptors (Chang et al., 2005), and dopamine derivatives by both PKA and MAPK pathways (Lee et al., 2008). Cellular modification of the latent nuclear antigen (LANA) (Cheng et al., 2009; Lu et al., 2006) and viral modification of cellular proteins (Sarek et al., 2010) are also indicated in controlling KSHV reactivation. "
    [Show abstract] [Hide abstract]
    ABSTRACT: We previously found that KSHV (HHV-8) lytic activation occurs during differentiation of oral keratinocytes in organotypic raft cultures. To further investigate the spatial and temporal aspects of KSHV lytic activation and the roles of integrins, cadherins, and calcium, we used rKSHV.219-infected primary oral keratinocytes in submerged, suspension, and direct suprabasal plating, models of differentiation. We found that early keratinocyte differentiation did not activate lytic KSHV in cells attached to a substratum, with activation only occurring in suprabasal cells. Temporally, KSHV lytic expression occurred between the expression of early and late differentiation markers. Keratinocytes differentiated in suspension culture, which mimics substratum loss that occurs with stratification, activated lytic KSHV. This lytic activation was inhibited by integrin engagement, showing that integrins are a control point for KSHV reactivation. A role for cadherins was not found. Elevated extracellular calcium was necessary, but not sufficient, for lytic activation.
    Virology 11/2010; 410(1):17-29. DOI:10.1016/j.virol.2010.10.023 · 3.32 Impact Factor
Show more

Preview (2 Sources)

11 Reads
Available from